Quantitative assessment of HER2/neu expression by real-time PCR and fluorescent in situ hybridization analysis in low-grade osteosarcoma

Oncology Reports

Volumn 12, Issue 1, 2004, Pages 125-128

  Lee, Woo In ^a   Bacchni, Patrizia ^c   Bertoni, Franco ^c   Maeng, Young Hee ^b   Park, Yong Koo ^a  

^a Kyung Hee University Hospital   (South Korea)

^b Seoguipo Medical Center   (South Korea)

^c UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

FISH; HER2 neu; Osteosarcoma; Real time PCR

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; PRIMER DNA;

ARTICLE; BONE TUMOR; CELL DIVISION; FLUORESCENCE IN SITU HYBRIDIZATION; GENETICS; HUMAN; KINETICS; METHODOLOGY; NUCLEOTIDE SEQUENCE; OSTEOSARCOMA; PATHOLOGY; POLYMERASE CHAIN REACTION;

BASE SEQUENCE; BONE NEOPLASMS; CELL DIVISION; DNA PRIMERS; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; KINETICS; OSTEOSARCOMA; POLYMERASE CHAIN REACTION; RECEPTOR, ERBB-2;

EID: 21644443230     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.12.1.125     Document Type: Article

References (17)

1. Natali PG, Nicotra MR, Bigotti A, et al. Expression of the p185 encoded by HER2 oncogene in normal and transformed human tissues. Int J Cancer 45: 457-461, 1990.
2. Cirisano FD and Karlan BY: The role of the HER-2/neu oncogene in gynecologic cancers. J Soc Gynecol Investig 3: 99-105, 1996. (Pubitemid 26139457)
3. Bongiorno PF, Whyte RI, Lesser EJ, et al. Alterations of K-ras, p53, and erbB-2/neu in human lung adenocarcinomas. J Thorac Cardiovasc Surg 107: 590-595, 1994.
4. Sanchez KM, Sweeney CJ, Mass R, et al. Evaluation of HER-2/ neu expression in prostatic adenocarcinoma: a requested for a standardized, organ specific methodology. Cancer 95: 1650-1655, 2002.
5. Schulze G: HER-2/neu gene product in serum - an oncoprotein in the diagnosis and therapy of breast carcinoma. Anticancer Res 23: 1007-1010, 2003.
6. Morabito A, Magnani E, Gion M, et al. Prognostic and predictive indicators in operable breast cancer. Clin Breast Cancer 3: 381-390, 2003.
7. Pauletti G, Dandekar S, Rong H, et al. Assessment of methods for tissue-based detection of the HER-2/neu alteration in human breast cancer: a direct comparison of fluorescence in situ hybridization and immunohistochemistry. J Clin Oncol 18: 3651-3664, 2000.
8. Gancberg D, Lespagnard L, Rouas G, et al. Sensitivity of HER-2/neu antibodies in archival tissue samples of invasive breast carcinomas. Correlation with oncogene amplification in 160 cases. Am J Clin Pathol 113: 675-682, 2000.
9. Bacci G, Ferrari S, Bertoni F, et al. Long-term outcome for patients with non-metastatic osteosarcoma of the extremity treated at the Istituto Ortopedico Rizzoli according to the Istituto Ortopedico Rizzoli/osteosarcoma-2 protocol: an updated report. J Clin Oncol 18: 4016-4027, 2000.
10. Kurt AM, Unni KK, McLeod RA and Pritchard DI: Low-grade intraosseous osteosarcoma. Cancer 65: 1418-1428, 1990. (Pubitemid 20097173)
11. Park YK, Ryu KN, Park HR and Kim DW: Low-grade osteosarcoma of the maxillary sinus. Skeletal Radiol 32: 161-164, 2003. (Pubitemid 36818118)
12. Trieb K and Kotz R: Proteins expressed in osteosarcoma and serum levels as prognostic factors. Int J Biochem Cell Biol 33: 11-17, 2001. (Pubitemid 32146463)
13. Akatsuka T, Wada T, Kokai Y, et al. ErbB2 expression is correlated with increased survival of patients with osteosarcoma. Cancer 94: 1397-1404, 2002.
14. Thomas GD, Giordano TJ, Sanders D, Biermann JS and Baker L: Absence of HER2/neu gene expression in osteosarcoma and skeletal Ewing's sarcoma. Clin Cancer Res 8: 788-793, 2002. (Pubitemid 34742109)
15. Maitra A, Wanzer D, Weinberg AG and Ashfaq R: Amplification of the HER-2/neu oncogene is uncommon in pediatric osteosarcomas. Cancer 92: 677-683, 2001. (Pubitemid 32735206)
16. Zhou H, Randall RL, Brothman AR, Maxwell T, Coffin CM and Goldsby RE: HER-2/neu expression in osteosarcoma increases risk of lung metastasis and can be associated with gene amplification. J Pediatr Hematol Oncol 25: 27-32, 2003. (Pubitemid 36070961)
17. Kilpatrick SE, Geisinger KR, King TS, et al. Clinicopathologic analysis of HER-2/neu immunoexpression among various histologic subtypes and grades of osteosarcoma. Mod Pathol 14: 1277-1283, 2001.